Most actively traded companies on the TSX

0

Some of the most active companies traded Friday on the Toronto Stock Exchange:

Toronto Stock Exchange (15,196.31, up 77.88 points):

Talon Metals Corp. (TSX:TLO). Miner. Up 0.5 of a cent, or 1.54 per cent, to 33 cents on 7.3 million shares.

Carpathian Gold Inc. (TSXCPN). Miner. Down 0.5 of a cent, or 16.67 per cent, to 2.5 cents on 5.9 million shares.

Mercator Minerals Ltd. (TSX:ML). Miner. Up 1.5 cents, or 30 per cent, to 6.5 cents on 5.8 million shares.

Crocotta Energy Inc. (TSX:CTA). Oil and gas. Up 12 cents, or 2.71 per cent, to $4.54 on 3.5 million shares.

B2Gold Corp. (TSX:BTO). Unchanged at $2.93 on 3.5 million shares.

Talisman Energy Inc. (TSX:TLM). Oil and gas. Up 35 cents, or 3.08 per cent, to $11.70 on 3.2 million shares.

Companies reporting major news:

Magna International Inc. (TSX:MG). Autos. Up $7.05, or 6.12 per cent, to $122.24 on 1.1 million shares. The auto parts giant says net income rose to $510 million or $2.32 a share during the quarter, up from $415 million, or $1.78 per share, a year ago. Sales increased six per cent to a record $9.46 billion. The company also boosted its sale forecast for the year.

SNC-Lavalin Group Inc. (TSX:SNC). Engineering. Down $1.71, or 2.92 per cent, to $56.91 on 880,674 shares. The Montreal-based engineering consulting and construction firm missed expectations, despite swinging to a $32.1 million profit on a 12.7-per-cent drop in revenues. The company said net income attributable to shareholders equalled 21 cents per share for the three months ended June 30, compared to a 25 cents per share or $37.7 million loss a year earlier.

Tekmira Pharmaceuticals Corp. (TSX:TKM). Biotechnology. Up $7.39, or 47.34 per cent, to $23.00 on 1.7 million shares. The Canadian drugmaker closed almost 50 per cent higher after U.S. health authorities eased safety restrictions on an experimental drug to treat the deadly Ebola virus. The U.S. Food and Drug Administration had recently placed a hold on the drug after safety issues emerged in human testing.

Leave a comment

Your email address will not be published. Required fields are marked *